BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6636048)

  • 1. Heparin inactivation during blood storage: its prevention by blood collection in citric acid, theophylline, adenosine, dipyridamole-C.T.A.D. mixture.
    Contant G; Gouault-Heilmann M; Martinoli JL
    Thromb Res; 1983 Jul; 31(2):365-74. PubMed ID: 6636048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Theophylline adenosine dipyridamole (CTAD) and citrate evaluation to survey unfractionated heparin treatment: a delayed centrifugation validation for anti-Xa measurement?].
    Billoir P; Clavier T; Guilbert A; Barbay V; Chrétien MH; Fresel M; Abriou C; Girault C; Le Cam Duchez V
    Ann Biol Clin (Paris); 2020 Feb; 78(1):27-34. PubMed ID: 32108577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is citrate theophylline adenosine dipyridamole (CTAD) better than citrate to survey unfractionated heparin treatment? Has delayed centrifugation a real impact on this survey?
    Billoir P; Clavier T; Guilbert A; Barbay V; Chrétien MH; Fresel M; Abriou C; Girault C; Le Cam Duchez V
    J Thromb Thrombolysis; 2019 Aug; 48(2):277-283. PubMed ID: 31098816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring treatments with unfractionated heparin: CTAD must be used instead of citrate as the anticoagulant solution when using partial-draw collection tubes. Results of a multicenter evaluation.
    Toulon P; Abecassis L; Smahi M; Ternisien C
    Thromb Res; 2010 Dec; 126(6):536-42. PubMed ID: 20950840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring heparin therapy by the activated partial thromboplastin time--the effect of pre-analytical conditions.
    van den Besselaar AM; Meeuwisse-Braun J; Jansen-Grüter R; Bertina RM
    Thromb Haemost; 1987 Apr; 57(2):226-31. PubMed ID: 3603414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A low volume specimen container suitable for monitoring the aPTT of heparinized patients.
    Ray MJ; Carroll PA; Just SJ; Hawson GA
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):805-7. PubMed ID: 8292732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of CTAD (citrate-theophylline-adenosine-dipyridamole) as a universal anticoagulant in dogs.
    Granat FA; Geffré A; Lucarelli LA; Braun JD; Trumel C; Bourgès-Abella NH
    J Vet Diagn Invest; 2017 Sep; 29(5):676-682. PubMed ID: 28673194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the anticoagulants EDTA and citrate, theophylline, adenosine, and dipyridamole (CTAD) for assessing platelet activation on the ADVIA 120 hematology system.
    Macey M; Azam U; McCarthy D; Webb L; Chapman ES; Okrongly D; Zelmanovic D; Newland A
    Clin Chem; 2002 Jun; 48(6 Pt 1):891-9. PubMed ID: 12029005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Photochemical decomposition of dipyridamole in aqueous solution and the utilization of citrate-theophylline-adenosine-dipyridamole anticoagulant for monitoring of heparin.
    van den Besselaar AM
    Int J Lab Hematol; 2010 Apr; 32(2):265-7. PubMed ID: 19552650
    [No Abstract]   [Full Text] [Related]  

  • 10. Heparin neutralization during collection and processing of blood inhibited by pyridoxal 5'-phosphate.
    van Putten J; van de Ruit M; Beunis M; Hemker HC
    Haemostasis; 1984; 14(3):253-61. PubMed ID: 6469101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric evaluation of platelet activation in blood collected into EDTA vs. Diatube-H, a sodium citrate solution supplemented with theophylline, adenosine, and dipyridamole.
    Kühne T; Hornstein A; Semple J; Chang W; Blanchette V; Freedman J
    Am J Hematol; 1995 Sep; 50(1):40-5. PubMed ID: 7668222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of anticoagulants and storage temperature on immature platelet fraction % (IPF%) values in stored samples measured by the automated hematology analyzer, XE-5000--utility of CTAD-anticoagulation and room temperature storage].
    Nishiyama M; Hayashi S; Kabutomori O; Yamanishi H; Suehisa E; Kurata Y; Kashiwagi H; Tomiyama Y
    Rinsho Byori; 2011 May; 59(5):452-8. PubMed ID: 21706858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of pre-analytical handling on haematological variables in minipigs.
    Olsen AK; Bladbjerg EM; Jensen AL; Hansen AK
    Lab Anim; 2001 Apr; 35(2):147-52. PubMed ID: 11315163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparin and citrate additive carryover during blood collection.
    Keppel MH; Auer S; Lippi G; von Meyer A; Cornes M; Felder TK; Oberkofler H; Mrazek C; Haschke-Becher E; Cadamuro J
    Clin Chem Lab Med; 2019 Nov; 57(12):1888-1896. PubMed ID: 31377734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of citrate buffer-fluoride mixture in Terumo tubes as an inhibitor of in vitro glycolysis.
    Bonetti G; Carta M; Montagnana M; Lo Cascio C; Bonfigli AR; Mosca A; Testa R;
    Biochem Med (Zagreb); 2016; 26(1):68-76. PubMed ID: 26981020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitivity of the activated partial thromboplastin time to heparin: effect of anticoagulant used for sample collection.
    Soloway HB; Cox SP; Donahoo JV
    Am J Clin Pathol; 1973 May; 59(5):760-2. PubMed ID: 4702695
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of time and temperature variables on routine coagulation tests.
    Adcock D; Kressin D; Marlar RA
    Blood Coagul Fibrinolysis; 1998 Sep; 9(6):463-70. PubMed ID: 9818995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A determination of the pre-analytical storage conditions for insulin like growth factor-I and type III procollagen peptide.
    Holt RI; Erotokritou-Mulligan I; Ridley SA; McHugh CM; Bassett EE; Cowan DA; Bartlett C; Sönksen PH
    Growth Horm IGF Res; 2009 Feb; 19(1):43-50. PubMed ID: 18617430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethylenediaminetetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood.
    Macey M; McCarthy D; Azam U; Milne T; Golledge P; Newland A
    Cytometry B Clin Cytom; 2003 Jan; 51(1):30-40. PubMed ID: 12500295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preanalytical variables and off-site blood collection: influences on the results of the prothrombin time/international normalized ratio test and implications for monitoring of oral anticoagulant therapy.
    van Geest-Daalderop JH; Mulder AB; Boonman-de Winter LJ; Hoekstra MM; van den Besselaar AM
    Clin Chem; 2005 Mar; 51(3):561-8. PubMed ID: 15650035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.